Status:

UNKNOWN

Research on the Application of Blood Collection Through Midline Catheters of Different Lengths

Lead Sponsor:

Sir Run Run Shaw Hospital

Conditions:

Catheter Complications

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Therefore, in this study, the investigators propose to use a randomized controlled prospective open study on inpatients with difficult blood collection, by comparing the effects of the application of ...

Detailed Description

Using block randomization, patients were randomized in 1:1:1 blocks into experimental arm 1(Long peripheral venous catheter), experimental arm 2(midline catheter), and control (short peripheral venous...

Eligibility Criteria

Inclusion

  • Meet the international diagnostic criteria for metabolic syndrome (such as ATP III criteria or domestic Diabetes Branch of Chinese Medical Association criteria).
  • The estimated treatment time of intravenous infusion is 1-4 weeks, and the nature of the infusion drug meets the indications of LPCs and MCs.
  • Blood samples should be collected more than 3 times during the hospital.

Exclusion

  • A history of radiotherapy, thrombosis, and trauma at the catheter site.
  • Plan to discharge from the hospital with the tube.
  • Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterate, etc.

Key Trial Info

Start Date :

October 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

162 Patients enrolled

Trial Details

Trial ID

NCT06014099

Start Date

October 27 2023

End Date

December 30 2025

Last Update

October 25 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Linfang Zhao

Hangzhou, Zhejiang, China, 310000